je.st
news
Tag: pharmaceuticals
Weekly CFO Sells Highllight: Facebook Inc, Vertex Pharmaceuticals Inc, Nike Inc.
2014-10-06 09:33:37| Footwear - Topix.net
On 08/20/2014, CFO David M Wehner sold 11,533 shares at an average price of $74.96. The price of the stock has increased by 3.5% since.
Griffin Securities Reiterates $95.00 Price Target for Ligand Pharmaceuticals
2014-09-27 08:07:22| Biotech - Topix.net
Griffin Securities' price objective points to a potential upside of 98.25% from the company's current price. A number of other firms have also recently commented on LGND.
Tags: price
target
securities
griffin
Allergan Said to Revive Talks to Buy Salix Pharmaceuticals
2014-09-23 14:20:33| Biotech - Topix.net
Allergan Inc. is in talks to acquire Salix Pharmaceuticals Ltd., reviving discussions that began in July in an effort to fend off a hostile takeover offer from Valeant Pharmaceuticals International Inc., people with knowledge of the matter said. The Botox-maker's talks with Salix went dormant for a few weeks because Salix wanted a higher price than Allergan wanted to pay, said the people, who asked not to be identified discussing private information.
Tags: buy
talks
pharmaceuticals
revive
Protecting Temperature-Sensitive Pharmaceuticals
2014-09-13 01:59:56| Logistics - Topix.net
As temperature-sensitive drug products travel worldwide, packaging serves as the barrier to a potentially hostile ambient environment. Temperature-controlled shippers not only maintain payloads within frozen, refrigerated, or controlled-room-temperature ranges, but also help brand owners and other supply chain participants meet good distribution practice standards.
Tags: protecting
pharmaceuticals
ACADIA Pharmaceuticals Receives FDA Breakthrough Therapy Designation For NUPLAZID (Pimavanserin) For Parkinson's Disease Psychosis
2014-09-03 11:32:21| drugdiscoveryonline Home Page
ACADIA Pharmaceuticals Inc. a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in neurological and related central nervous system disorders, recently announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to NUPLAZID (pimavanserin) for the treatment of Parkinson’s disease psychosis
Tags: disease
therapy
receives
designation
Sites : [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] next »